Your health history
Including metabolic conditions, gastrointestinal history, prior surgeries, pregnancy considerations, and other relevant factors.
KERNX Learning Center
Back to homeSemaglutide vs. Tirzepatide
They are not interchangeable. Here is a clean comparison, and why your provider’s judgment matters more than internet hype.
The comparison
| Feature | Semaglutide | Tirzepatide |
|---|---|---|
| Medication class | GLP-1 receptor agonist | GIP and GLP-1 receptor agonist |
| Typical schedule | Usually once weekly when prescribed in injectable form | Usually once weekly when prescribed |
| How it supports care | Acts on pathways related to appetite and glucose regulation | Acts on two pathways related to appetite and metabolic regulation |
| Starting treatment | Generally begins at a lower dose with gradual adjustment | Generally begins at a lower dose with gradual adjustment |
| Best fit | Determined by a licensed provider after reviewing your history, goals, risks, medication access, and response to prior treatment. | |
No comparison chart can tell you what is safest or most appropriate for your body. That decision belongs to you and your licensed provider.
What your provider considers
Current medications
Potential interactions and overlapping effects must be reviewed before a prescription is considered.
Prior treatment response
What you have tried, what helped, and what side effects you experienced can shape the next step.
Access and continuity
A sustainable treatment plan includes reliable follow up, appropriate monitoring, and realistic expectations.
There is no universal “winner”
Clinical studies can compare average outcomes in specific populations and branded products, but averages do not predict an individual result. The right choice depends on your medical profile and your provider’s judgment, not which medication is trending online.
Ready for a physician led plan?
Complete the assessment. A licensed provider reviews your health history and determines whether treatment is appropriate.
Get Started →